Standout Papers

Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults 2023 2026 2024364
  1. Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults (2023)
    Alberto Papi, Michael G. Ison et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 55 standout
Sub-graph 1 of 22

Citing Papers

Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study
2025 Standout
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
2 intermediate papers

Works of Laura Cámpora being referenced

Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
2023 Standout
Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study
2017
and 2 more

Author Peers

Author Last Decade Papers Cites
Laura Cámpora 530 68 172 105 12 606
J Rush 528 16 143 18 9 700
S L Spruance 577 115 87 10 19 687
Chengbin Wang 542 15 240 9 22 604
M Minamitani 572 10 279 170 26 679
Susan B. Manoff 459 11 202 34 20 671
Daniel Desgrandchamps 399 4 162 105 23 631
Gun Carlström 299 9 96 59 30 709
Pieter J. Wismans 260 27 114 34 26 652
Catherine M. Hayden 140 53 49 170 24 660
Hideomi Asanuma 487 65 139 7 21 652

All Works

Loading papers...

Rankless by CCL
2026